Decentralization in Action: What Oncology Trials Look Like Now

In this video-on-demand, Dr. Shaalan Beg, MD, MS, Vice President, Oncology, at Science 37 met recently with Dr. Aasma Shaukat, Professor of Gastroenterology and Medicine, NYU Grossman School of Medicine and Andrew J. Mckenzie, PhD, Vice President, Personalized Medicine, Sarah Cannon for a discussion on what current clinical research looks like with oncology trials.

The panel spoke about the shared value that agile approaches to clinical trials deliver to patients, sponsors, sites and CROs — giving examples of how decentralized elements are incorporated in oncology trials today, and how the landscape will change in the years to come.